Latigo Biotherapeutics
Small molecule therapeutics targeting peripheral nervous system pain pathways
- Sector
- Biotech
- Headquarters
- THOUSAND OAKS, CA
- Latest Form D
- $50M, Feb 2025
- Total capital
- $50M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $50M
- 1 Form D · last Feb 2025
- 20 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 30 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$50M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Beth SeidenbergDirectorNamed in SEC Form D filings
- Deborah PalestrantDirectorNamed in SEC Form D filings
- Jim TananbaumDirectorNamed in SEC Form D filings
- Kevin RaidyDirectorNamed in SEC Form D filings
- Nancy StaglianoDirectorNamed in SEC Form D filings
- Nima FarzanExecutive Officer, DirectorNamed in SEC Form D filings
Show all 8 people
- Tim LugoExecutive OfficerNamed in SEC Form D filings
- Tim WalbertDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 30- PendingSodium Channel Blocking Compounds, Derivatives Thereof, And Methods Of Their UseUSPTOApplication 18833138
- PendingSodium Channel Blocking Compounds, Derivatives Thereof, And Methods Of Their UseUSPTOApplication PCTUS2025033937
- PendingSodium Channel Blocking Compounds, Derivatives Thereof, And Methods Of Their UseUSPTOApplication 63727458
Show all 30 patent records
- Sodium Channel Blocking Compounds, Derivatives Thereof, And Methods Of Their UseMay 15, 2025 · Application 18833138Pending
- Sodium Channel Blocking Compounds, Derivatives Thereof, And Methods Of Their UseApplication PCTUS2025033937Pending
- Sodium Channel Blocking Compounds, Derivatives Thereof, And Methods Of Their UseApplication 63727458Pending
- Sodium Channel Blocking Compounds, Derivatives Thereof, And Methods Of Their UseApplication PCTUS2024040342Pending
- Sodium Channel Blocking Compounds, Derivatives Thereof, And Methods Of Their UseApplication 63661225Pending
- Sodium Channel Blocking Compounds, Derivatives Thereof, And Methods Of Their UseApplication 63570708Pending
- Sodium Channel Blocking Compounds, Derivatives Thereof, And Methods Of Their UseApplication PCTUS2023032280Pending
- Sodium Channel Blocking Compounds, Derivatives Thereof, And Methods Of Their UseApplication 63530158Pending
- Sodium Channel Blocking Compounds, Derivatives Thereof, And Methods Of Their UseApplication PCTUS2023012172Pending
- Sodium Channel Blocking Compounds, Derivatives Thereof, And Methods Of Their UseApplication 63405094Pending
- Sodium Channel Blocking Compounds, Derivatives Thereof, And Methods Of Their UseApplication 63405151Pending
- Sodium Channel Blocking Compounds, Derivatives Thereof, And Methods Of Their UseApplication 63405096Pending
- Sodium Channel Blocking Compounds, Derivatives Thereof, And Methods Of Their UseApplication 63405120Pending
- Sodium Channel Blocking Compounds, Derivatives Thereof, And Methods Of Their UseApplication 63354509Pending
- Sodium Channel Blocking Compounds, Derivatives Thereof, And Methods Of Their UseApplication 63306695Pending
- 6-SUBSTITUTED-PYRIDAZINE-4- Carboxamide Compounds And Derivatives Thereof And Methods Of Their UseApplication 63252459Pending
- 6-SUBSTITUTED-PYRIDAZINE-4-CARBOXAMIDE Compounds And Derivatives Thereof And Methods Of Their UseApplication 63252469Pending
- Methyl-substituted Pyridine And Pyridazine Compounds, Derivatives Thereof, And Methods Of Their UseApplication 63237368Pending
- 6-SUBSTITUTED-PYRIDAZINE-4-CARBOXAMIDE Compounds And Derivatives Thereof And Methods Of Their UseApplication 63196713Pending
- 6-SUBSTITUTED-PYRIDAZINE-4-CARBOXAMIDE Compounds And Derivatives Thereof And Methods Of Their UseApplication 63196715Pending
- Methyl-substituted Pyridine And Pyridazine Compounds, Derivatives Thereof, And Methods Of Their UseApplication 63185692Pending
- Methyl-substituted Pyridine And Pyridazine Compounds, Derivatives Thereof, And Methods Of Their UseApplication 63185164Pending
- Methyl-substituted Pyridine And Pyridazine Compounds, Derivatives Thereof, And Methods Of Their UseApplication 63159718Pending
- Deuterated Pyridine And Pyridazine Carboxamide Compounds, Derivatives Thereof, And Methods Of Their UseApplication 63159720Pending
- Sodium Channel Blocking Compounds, Derivatives Thereof, And Methods Of Their UseApplication PCTUS2026014115Pending
- Sodium Channel Blocking Compounds, Derivatives Thereof, And Methods Of Their UseApplication 63916134Pending
- Sodium Channel Blocking Compounds, Derivatives Thereof, And Methods Of Their UseApplication 63754716Pending
- Sodium Channel Blocking Compounds, Derivatives Thereof, And Methods Of Their UseApplication 19101138Pending
- Sodium Channel Blocking Compounds, Derivatives Thereof, And Methods Of Their UseApplication PCTUS2025057716Pending
- Sodium Channel Blocking Compounds, Derivatives Thereof, And Methods Of Their UseApplication 19503715Pending
Related companies, and why
- NILO Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Bectas Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Cime Therapeutics Inc.Similar federal contract value in Biotech · null in contracts
- Tamarind Bio, Inc.Similar federal contract value in Biotech · null in contracts
- Animerra, Inc.Similar federal contract value in Biotech · null in contracts
- Enquyst Technologies Inc.Similar federal contract value in Biotech · null in contracts
Press
Inside Latigo Biotherapeutics’ IPO: A Non-Opioid Pain Bet Goes Public24/7 Wall St.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .